Article Versions Notes

Gupta H, Min B-H, Ganesan R, Gebru YA, Sharma SP, Park E, Won S-M, Jeong J-J, Lee S-B, Cha M-G, et al. Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role. Biomedicines. 2022; 10(3):550. https://doi.org/10.3390/biomedicines10030550

Gupta, Haripriya, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, and et al. 2022. "Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role" Biomedicines 10, no. 3: 550. https://doi.org/10.3390/biomedicines10030550

Gupta, H., Min, B.-H., Ganesan, R., Gebru, Y. A., Sharma, S. P., Park, E., Won, S.-M., Jeong, J.-J., Lee, S.-B., Cha, M.-G., Kwon, G.-H., Jeong, M.-K., Hyun, J.-Y., Eom, J.-A., Park, H.-J., Yoon, S.-J., Choi, M.-R., Kim, D.-J., & Suk, K.-T. (2022). Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role. Biomedicines, 10(3), 550. https://doi.org/10.3390/biomedicines10030550